Characteristics and conflicts of interest at Food and Drug Administration Gastrointestinal Drug Advisory Committee meetings.
<h4>Introduction</h4>The United States Food and Drug Administration (FDA) Gastrointestinal Drug Advisory Committee (GIDAC) is involved in gastrointestinal drug application reviews. Characteristics and conflicts of interest (COI) in GIDAC meetings are not well described. This study analyz...
Enregistré dans:
Auteurs principaux: | Rishad Khan, Karam Elsolh, Nikko Gimpaya, Michael A Scaffidi, Rishi Bansal, Samir C Grover |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f4fba966226b48adb7a4e44f6e42689c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Automated detection of cecal intubation with variable bowel preparation using a deep convolutional neural network
par: Daniel J. Low, et autres
Publié: (2021) -
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.
par: Kristin Rising, et autres
Publié: (2008) -
Evaluation of an advisory committee as a model for patient engagement
par: Cynthia Kendell, et autres
Publié: (2014) -
Meeting of the Advisory Committee of the Caribbean Planners Network (CPN)
Publié: (2014) -
Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library
par: Junyuan Cao, et autres
Publié: (2021)